Albion Capital Group logo

Albion Capital Group

Europe, England, United Kingdom, London

Description

Albion Capital Group LLP is a prominent independent investment manager based in London, United Kingdom, known for its extensive track record in backing innovative companies poised for significant growth and change. The firm manages a substantial portfolio, overseeing over £1.4 billion (approximately $1.78 billion) in capital across various funds, including several Venture Capital Trusts (VCTs). Their investment philosophy centers on providing long-term support to businesses, fostering their development from early to growth stages.

With a strategic focus on specific high-growth sectors, Albion Capital primarily targets opportunities within B2B software, healthcare, and environmental technologies. Within these domains, they seek out companies demonstrating strong potential for market disruption and sustainable expansion. The firm has a rich history of supporting entrepreneurial ventures, having invested in over 200 companies to date, showcasing their deep experience and commitment to the UK's innovation ecosystem.

Albion Capital typically provides initial funding cheques ranging from £2 million to £10 million (approximately $2.54 million to $12.7 million). This substantial initial investment is often complemented by further follow-on funding as companies achieve milestones and require additional capital for scaling. Their approach emphasizes building strong partnerships with management teams, offering not just financial backing but also strategic guidance and operational support to help portfolio companies navigate challenges and capitalize on growth opportunities.

Investor Profile

Albion Capital Group has backed more than 59 startups, with 0 new investments in the last 12 months alone. The firm has led 12 rounds, about 20% of its total and boasts 12 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Seed, Series A rounds (top funding stages).
  • Majority of deals are located in United Kingdom, United States, Malaysia.
  • Strong thematic focus on Software, Health Care, Developer Platform.
  • Typical check size: $2.5M – $12.7M.

Stage Focus

  • Series Unknown (85%)
  • Seed (7%)
  • Series A (3%)
  • Post Ipo Equity (3%)
  • Series B (2%)

Country Focus

  • United Kingdom (81%)
  • United States (17%)
  • Malaysia (2%)

Industry Focus

  • Software
  • Health Care
  • Developer Platform
  • Enterprise
  • Medical
  • Renewable Energy
  • Biotechnology
  • Biofuel
  • Computer
  • Supply Chain Management
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Albion Capital Group frequently co-invest with?

Skip Capital
Oceania, New South Wales, Australia, Sydney
Co-Investments: 1
Service Provider Capital
North America, Colorado, United States, Golden
Co-Investments: 1
Album VC
North America, Utah, United States, Lehi
Co-Investments: 1
FI
Europe, England, United Kingdom, London
Co-Investments: 2
TrueSight Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
Scottish Investment Bank
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 2
Oxford Capital
Europe, Oxfordshire, United Kingdom, Oxford
Co-Investments: 13
Select Venture Partners
North America, Virginia, United States, Fredericksburg
Co-Investments: 1
Stride.VC
Europe, England, United Kingdom, London
Co-Investments: 1
Seed Equity Venture Partners
North America, Utah, United States, Salt Lake City
Co-Investments: 1

What are some of recent deals done by Albion Capital Group?

Pando

London, England, United Kingdom

Forward is now Pando! Pando is an essential tool for teamwork and secure collaboration in health and social care.

Health CaremHealthPharmaceutical
SeedJan 28, 2020
Amount Raised: $5,000,000
G.Network

London, England, United Kingdom

G.Network is the next generation communications service provider exclusively focused on Central London.

Communications InfrastructureWired Telecommunications
Series UnknownJun 14, 2017
Amount Raised: $5,962,470
Relayware

Jersey City, New Jersey, United States

Relayware provides business-to-business collaboration and multichannel communication solutions.

B2BCollaborationMobile AppsSoftware
Series UnknownMay 9, 2016
Amount Raised: $11,000,000
Innovation Broking

Watford, Hertford, United Kingdom

Innovation Broking is an independent commercial insurance broker.

Commercial InsuranceInsurance
Series UnknownNov 12, 2015
Amount Raised: $3,046,059
Consensus

Lehi, Utah, United States

Consensus is an intelligent demo automation platform that automates custom product demos to accelerate sales.

B2BMarketing AutomationProductivity ToolsSaaSSales Automation
SeedApr 9, 2015
Amount Raised: $2,800,000
The Charnwood Pub

Shifnal, Shropshire, United Kingdom

The Charnwood Pub Company owns and operates 10 public houses.

LifestyleNightclubsRestaurants
Series UnknownDec 5, 2014
Amount Raised: $156,016
KERN Ventures

Kuala Lumpur, Kuala Lumpur, Malaysia

KERN Ventures is an investment firm focusing on providing funding, consultancy and strategy advice to start-up companies.

FinanceFinancial ServicesVenture Capital
Series UnknownNov 19, 2014
Amount Raised: $2,431,014
Chonais Holdings

London, England, United Kingdom

Chonais Holdings is a renewable energy company based in London, United Kingdom.

EnergyEnergy ManagementRenewable Energy
Series UnknownNov 19, 2014
Amount Raised: $3,999,410
Haemostatix

Nottingham, Nottingham, United Kingdom

Haemostatix has developed a new class of active clotting agent, or "haemostat" for the control of bleeding.

BiotechnologyClinical TrialsHealth CareMedical
Series UnknownNov 11, 2014
Amount Raised: $98,083
DYSIS Medical

Livingston, West Lothian, United Kingdom

DYSIS Medical is focused on developing imaging systems for the non-invasive, in-vivo detection of cancerous and pre-cancerous lesions.

Health CareLife ScienceManufacturingMedicalMedical DevicePharmaceutical
Series UnknownOct 21, 2014
Amount Raised: $58,555